Home › DARPA Awards Contract to MBio

DARPA Awards Contract to MBio

Feb 14, 2018

NEW YORK (360Dx) – MBio Diagnostics today announced it has been awarded a Phase II contract from the US Defense Advanced Research Projects Agency for the further development of a portable multiplexed immunoassay system.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Mar
14
Featured Webinar

A Multiomics Approach to Defining the Nature of Early Malignant Transformations of the Immune System

In this webinar, Dr. Wendy Béguelin of Weill Cornell Medicine will discuss how she used the BD Rhapsody single-cell RNA-seq platform and YFP floxed reporter mouse models to study how lymphoma-associated mutations disrupt the immune system by affecting GC B-cell states, explaining the biology of initiation of low-grade follicular lymphoma.

What's Popular?

In Immunoassays

  1. Quidel Q4 Revenues Up 15 Percent

  2. Prostate Cancer Test Deal Forged by Minomic, Cirrus Dx

  3. Increased Monitoring of Biologics Could Boost Demand for T-mAb Testing

    Premium

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb LLC.  All Rights Reserved.